https://proton.me/blog/proton-standard-notes-join-forces
Proton and the end-to-end encrypted note-taking app Standard Notes are joining forces. We’ve long been admirers and are excited to welcome Mo and his team.
https://www.youtube.com/watch?v=UGN2l-XY_EE
Over two years we follow the first ever medical trial of psilocybin (the psychoactive ingredient in magic mushrooms) being used to treat a group of volunteer...
Hello everyone,
As a former ice hockey player, I'm considering getting inline skates for my commute to work. However, I'm a bit unsure about which type to choose, especially since the pavement and roads in my area vary in quality.
Could you please recommend a suitable type of skate?
Thanks!
https://www.youtube.com/watch?v=hLCVGRnEk9c
This week we interview 2-time Stanley Cup champion, Daniel Carcillo (@danielcarcillo13 on Instagram and @carbombboom13 on Twitter) about his journey through ...
https://www.youtube.com/watch?v=8kfGaVAXeMY
A clinical psychologist from Imperial College describes how Magic Mushrooms (Psilocybin), when used in a therapeutic setting, have been found to be a very ef...
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0308-4
Background Microdosing psychedelics is the practice of consuming very low, sub-hallucinogenic doses of a psychedelic substance, such as lysergic acid diethylamide (LSD) or psilocybin-containing mushrooms. According to media reports, microdosing has grown in popularity, yet the scientific literature contains minimal research on this practice. There has been limited reporting on adverse events associated with microdosing, and the experiences of microdosers in community samples have not been categorized. Methods In the present study, we develop a codebook of microdosing benefits and challenges (MDBC) based on the qualitative reports of a real-world sample of 278 microdosers. Results We describe novel findings, both in terms of beneficial outcomes, such as improved mood (26.6%) and focus (14.8%), and in terms of challenging outcomes, such as physiological discomfort (18.0%) and increased anxiety (6.7%). We also show parallels between benefits and drawbacks and discuss the implications of these results. We probe for substance-dependent differences, finding that psilocybin-only users report the benefits of microdosing were more important than other users report. Conclusions These mixed-methods results help summarize and frame the experiences reported by an active microdosing community as high-potential avenues for future scientific research. The MDBC taxonomy reported here informs future research, leveraging participant reports to distil the highest-potential intervention targets so research funding can be efficiently allocated. Microdosing research complements the full-dose literature as clinical treatments are developed and neuropharmacological mechanisms are sought. This framework aims to inform researchers and clinicians as experimental microdosing research begins in earnest in the years to come.
Hi guys,
Do you use any decntrlised storage? If yes could you recommend any?
Thx
Hi guys
What open source non-custodial lightening wallet would you recommend?
@badgrandpa
@lemmy.world